By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fitch Ratings late on Tuesday affirmed several ratings of BBB+ for Agilent Technologies.

The BBB+ ratings, which translate to good credit quality, were affirmed for Agilent's Issuer Default Rating, senior unsecured revolving credit facility, and senior unsecured notes. Fitch's actions affect about $2.6 billion of debt, including an undrawn $400 million revolving credit facility that expires in 2016, Fitch said.

It rated Agilent's outlook Stable.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.